Christensen E. et al. observed that PD-L1 on monocytes increased with COVID-19 severity and in deteriorating patients during the first week of follow-up, whereas in recovered patients, there was a decrease in the expression of PD-L1 [50]. The gene discussed is CD274; the disease is COVID-19.